Exogenous gene expression in tumors: noninvasive quantification with functional and anatomic imaging in a mouse model

Area of Science:

• * Molecular Imaging
• * Cancer Research
• * Gene Therapy

Background:

• * Noninvasive quantification of gene expression is crucial for monitoring therapeutic efficacy.
• * Somatostatin receptor type 2A (SSTR2A) is a key target in various cancers.
• * Current methods for assessing gene transfer in tumors have limitations.

Purpose of the Study:

• * To evaluate the utility of combined functional and anatomic imaging for in vivo quantification of SSTR2A gene chimera expression.
• * To correlate imaging findings with ex vivo measurements of gene expression and tumor weight.

Main Methods:

• * Animal models with varying levels of SSTR2A gene chimera expression were utilized.
• * Indium 111 octreotide was used as a radiopharmaceutical for functional imaging (planar and SPECT).
• * Magnetic resonance (MR) imaging was employed for anatomic assessment and tumor weight determination.

Main Results:

• * High correlations were observed between in vivo functional imaging (planar and SPECT) and ex vivo radiopharmaceutical uptake (r = 0.94 and r = 0.90, respectively).
• * Tumor weights derived from MR imaging strongly correlated with ex vivo measurements (r = 0.98).
• * Combined imaging accurately quantified gene transfer and tumor burden in vivo.

Conclusions:

• * A combination of functional and anatomic imaging techniques provides a reliable method for noninvasive quantification of gene transfer in tumors.
• * This approach holds promise for in vivo monitoring of gene therapy efficacy.
• * The study validates the use of multimodal imaging in preclinical cancer research.